Replimune Group, Inc.
REPL
$8.02
$0.040.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.95M | 26.64M | 32.80M | 25.57M | 18.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.53M | 83.91M | 90.00M | 78.78M | 65.64M |
| Operating Income | -71.53M | -83.91M | -90.00M | -78.78M | -65.64M |
| Income Before Tax | -71.24M | -83.10M | -86.69M | -74.24M | -65.77M |
| Income Tax Expenses | -311.00K | -- | -- | -107.00K | 575.00K |
| Earnings from Continuing Operations | -70.93M | -83.10M | -86.69M | -74.13M | -66.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.93M | -83.10M | -86.69M | -74.13M | -66.34M |
| EBIT | -71.53M | -83.91M | -90.00M | -78.78M | -65.64M |
| EBITDA | -69.16M | -83.37M | -89.43M | -75.10M | -63.23M |
| EPS Basic | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| Normalized Basic EPS | -0.48 | -0.57 | -0.59 | -0.51 | -0.49 |
| EPS Diluted | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| Normalized Diluted EPS | -0.48 | -0.57 | -0.59 | -0.51 | -0.49 |
| Average Basic Shares Outstanding | 92.19M | 91.92M | 91.52M | 90.92M | 83.50M |
| Average Diluted Shares Outstanding | 92.19M | 91.92M | 91.52M | 90.92M | 83.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |